EditCo's journey began within the pioneering gene editing landscape of Synthego, where, for the past five years, it has honed its expertise and contributed to the gene editing revolution. EditCo's experience has solidified its understanding of the indispensable role that high-quality, readily available reagents play in propelling scientific breakthroughs.
CRISPR technology stands at the forefront of discovery research, bridging the gap between fundamental biological insights and their applicat...ion in addressing real-world challenges. The company has minimized cell functionality and performance variability by leveraging its proprietary automated workflows, enabling researchers to achieve groundbreaking discoveries confidently. By applying the principles of convenience, quality, and swift delivery traditionally associated with reagents, EditCo aims to revolutionize the application of engineered cells, ensuring they are as dependable and reproducible as any standard laboratory reagent.
This visionary shift is not just a change in our product offerings but a reimagining of how scientific research is conducted. EditCo is committed to empowering the scientific community with tools that accelerate the pace of discovery and open new avenues for innovation.